PREISSNER KLAUS T

No ORCID on file · 14 papers in corpus · active 2003
2003

The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…

2003

The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…

2003

The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…

2003

The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…

2003

The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…

2003

The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…

2003

The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…

2003

Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…

2003

Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…

2003

Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…

2003

Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…

2003

Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…

2003

Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…

2003

Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…